Incomplete cross tolerance and multiple mu opioid peptide receptors

Trends in Pharmacological Sciences

Volumn 22, Issue 2, 2001, Pages 67-70

  Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA FUNALTREXAMINE; DIAMORPHINE; FENTANYL; METHADONE; MORPHINE; MORPHINE 6 ACETATE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NALOXONAZINE; RECEPTOR SUBTYPE;

ALTERNATIVE RNA SPLICING; ANALGESIA; ARTICLE; BINDING AFFINITY; DRUG CROSS TOLERANCE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; KNOCKOUT GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT;

EID: 0035252727     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01616-3     Document Type: Review

References (27)

1. Opioid rotation for cancer pain: Rationale and clinical aspects
2. Pain
3. Pharmacological mechanisms of opioid analgesics
4. Classification of multiple morphine and enkephalin binding sites in the central nervous system
5. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities
6. Mapping of opioid receptors using antisense oligodeoxynucleotides: Correlating their molecular biology and pharmacology
7. 3-Methoxynaltrexone, a selective heroin/morphine-6β-glucuronide antagonist
8. Antagonism of heroin and morphine self-administration in rats by the morphine-6β-glucuronide antagonist 3-0-methylnaltrexone
9. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia
10. Opiate receptors in mice: Genetic differences
11. Strain differences in opiate receptors in mouse brain
12. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains
13. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the μ and δ opioid receptors
14. μ opiate receptor: cDNA cloning and expression
15. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor
16. Antisense mapping the MOR-1 opioid receptor: Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor
17. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
18. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
19. μ opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
20. Retention of heroin and morphine-6 β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1
21. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR 1B) which differs in agonist induced desensitization from rMOR1
22. Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain
23. Identification and characterization of three new alternatively spliced mu opioid receptor isoforms
24. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C and MOR-1-like immunoreactivity: Evidence for region-specific processing
25. Comparative distribution of the mu opioid receptor splice variant MOR-1D-like immunoreactivity with MOR-1- and MOR-1C-like immunoreactivities in the murine central nervous system
26. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F
27. Functional characterization of several alternatively spliced mu opioid receptor (MOR-1) isoforms